AU2002223013A1 - Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same - Google Patents

Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same

Info

Publication number
AU2002223013A1
AU2002223013A1 AU2002223013A AU2301302A AU2002223013A1 AU 2002223013 A1 AU2002223013 A1 AU 2002223013A1 AU 2002223013 A AU2002223013 A AU 2002223013A AU 2301302 A AU2301302 A AU 2301302A AU 2002223013 A1 AU2002223013 A1 AU 2002223013A1
Authority
AU
Australia
Prior art keywords
pharmaceutical
parenteral administration
obtaining same
oxaliplatinum
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002223013A
Inventor
Christine Deuschel
Houssam Ibrahim
Henri Pourrat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debiopharm SA
Original Assignee
Debiopharm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm SA filed Critical Debiopharm SA
Publication of AU2002223013A1 publication Critical patent/AU2002223013A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
AU2002223013A 2000-12-12 2001-12-12 Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same Abandoned AU2002223013A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH24222000 2000-12-12
CH2422/00 2000-12-12
PCT/CH2001/000708 WO2002047725A2 (en) 2000-12-12 2001-12-12 Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same

Publications (1)

Publication Number Publication Date
AU2002223013A1 true AU2002223013A1 (en) 2002-06-24

Family

ID=4569152

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002223013A Abandoned AU2002223013A1 (en) 2000-12-12 2001-12-12 Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same

Country Status (4)

Country Link
US (1) US7012072B2 (en)
EP (1) EP1341555A2 (en)
AU (1) AU2002223013A1 (en)
WO (1) WO2002047725A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022842A1 (en) * 2002-06-03 2004-02-05 Mebiopharm Co., Ltd. Liposome preparations containing oxaliplatin
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions
US20060063720A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Oxaliplatin solution concentrate
JP2006248978A (en) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd New liposome preparation
DE102005038347A1 (en) * 2005-08-11 2007-02-15 Hexal Ag Preparation of an oxaliplatin solution and container and container set with the solution
US20090076139A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched oxalplatin
JP5759464B2 (en) 2009-09-21 2015-08-05 ジェイダブリュー ファーマシューティカル コーポレイション Oxaliplatin nanoparticles and method for producing the same
JP5314790B1 (en) * 2012-07-09 2013-10-16 東和薬品株式会社 Oxaliplatin-containing pharmaceutical composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439181A (en) 1981-01-26 1984-03-27 Regents Of The University Of Minnesota Polyol-hormone mixture for use in chronic parenteral hormone administration
AU5416394A (en) 1992-11-24 1994-06-22 Debiopharm S.A. Cisplatinum/oxaliplatinum combination
DK0689426T3 (en) 1993-03-22 2000-10-30 Cognis Australia Pty Ltd Therapeutic agent for the treatment of melanomas
IL114852A (en) 1994-08-08 2000-02-29 Debiopharm Sa Pharmaceutically stable preparation of oxaliplatinum
JP2001513110A (en) 1997-03-07 2001-08-28 サノフィ−シンテラボ インコーポレイティド Tumor treatment methods
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
AU762138B2 (en) 1998-10-14 2003-06-19 Debiopharm S.A. Oxaliplatinum preparation packaging
ES2206288T3 (en) 1999-08-30 2004-05-16 Debiopharm S.A. STABLE PHARMACEUTICAL PREPARATION OF OXYLIPLATINE FOR PARENTERAL ADMINISTRATION.

Also Published As

Publication number Publication date
WO2002047725A3 (en) 2002-10-10
WO2002047725A2 (en) 2002-06-20
US20040127557A1 (en) 2004-07-01
EP1341555A2 (en) 2003-09-10
US7012072B2 (en) 2006-03-14

Similar Documents

Publication Publication Date Title
AU6271401A (en) Drug administering system and administering method
AU3403201A (en) Drug delivery device and method
AU2002252152A1 (en) Tissue electroperforation for enhanced drug delivery and sampling
AU2001240753A1 (en) Lipid nanocapsules, preparation method and use as medicine
AU2002236647A1 (en) Method and device for administering medication and/or placebo
AU2001294808A1 (en) Catecholamine pharmaceutical compositions and methods
AU1267400A (en) Pharmaceutical moxifloxacin preparation
AU2002239397A1 (en) Drug formulation having improved oral tolerability
AU2001226029A1 (en) Pharmaceutical formulation and method for pulmonary and oral delivery
AU5686400A (en) Method for producing quickly decomposable solid pharmaceutical preparations
AU2001284444A1 (en) Preparations for oral administration
IL145559A0 (en) Tolperison-containing pharmaceutical preparation for oral administration
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
AU2002217229A1 (en) Pharmaceutical dronedarone composition for parenteral administration
AU2002223013A1 (en) Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
HUP0303597A3 (en) Diposable vaginal cannula for the simultaneous administration of drugs in different forms
AU2001293907A1 (en) Method for preparing camptothecin and its derivatives
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
AU3926000A (en) Methods and compositions for drug delivery
AU5483600A (en) Pharmaceutical materials and methods for their preparation and use
AU2001241060A1 (en) Gel preparations for oral administration having improved preservation properties
AU2001228784A1 (en) Inositol derivatives and their pharmaceutical use
AU2002223645A1 (en) Method for producing readily soluble medicament formulations and corresponding formulations
IL132666A0 (en) Phytoestrogenic pharmaceutical preparations